Home > Boards > US Listed > Biotechs > iBio, Inc. (IBIO)

All, true...I go by filings and company PRs...and

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
mastaflash Member Profile
 
Followed By 162
Posts 33,437
Boards Moderated 1
Alias Born 01/26/05
160x600 placeholder
iBio says successful in preclinical studies for subunit COVID-19 vaccine candidate Seeking Alpha - 7/16/2021 7:24:36 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/16/2021 6:04:34 AM
iBio Reports Successful Preclinical Immunization Studies with Next-Gen Nucleocapsid COVID-19 Vaccine Candidate GlobeNewswire Inc. - 7/15/2021 5:10:00 PM
iBio establishes oncology drug discovery pipeline with three new antibody programs Seeking Alpha - 7/8/2021 4:23:04 PM
iBio Establishes Oncology Drug Discovery Pipeline with Three New Antibody Programs GlobeNewswire Inc. - 7/8/2021 4:15:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/9/2021 5:20:28 PM
iBio adds veteran biopharmaceutical executive to board of directors Seeking Alpha - 6/9/2021 4:44:08 PM
iBio Further Strengthens Board with Appointment of Veteran Biopharmaceutical Executive, Eef Schimmelpennink GlobeNewswire Inc. - 6/9/2021 4:30:00 PM
iBio to Present at the UBS Global Healthcare Virtual Conference GlobeNewswire Inc. - 5/19/2021 4:30:00 PM
iBio Q1 net loss widens as expenses soar year-over-year; shares fall 6% Seeking Alpha - 5/17/2021 10:08:32 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/17/2021 7:16:10 AM
iBio revenue in-line Seeking Alpha - 5/17/2021 7:04:02 AM
iBio Reports Fiscal Third Quarter 2021 Financial Results and Provides Corporate Update GlobeNewswire Inc. - 5/17/2021 7:00:00 AM
iBio to Report Fiscal 2021 Third Quarter Financial Results and Provide Corporate Update on Monday, May 17, 2021 GlobeNewswire Inc. - 5/10/2021 8:15:00 AM
ChemoCentryx downgraded on narrow Adcom backing, Tilray jumps on double upgrade; in today’s analyst action Seeking Alpha - 5/7/2021 8:57:30 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/6/2021 4:46:04 PM
iBio shares surge on COVID-19 study update Seeking Alpha - 5/6/2021 4:42:34 PM
iBio Reports Successful COVID-19 Vaccine Toxicology Study Results and Announces Next-Gen COVID-19 Vaccine Program GlobeNewswire Inc. - 5/6/2021 4:15:00 PM
Regional Health Properties, Chiasma leads healthcare gainers; Cocrystal Pharma, Esperion Therapeutics among major losers Seeking Alpha - 5/5/2021 11:00:10 AM
ATVI, TEVA, AYX and LYFT among notable premarket gainers Seeking Alpha - 5/5/2021 8:24:13 AM
iBio shares surge after resolving Fraunhofer USA lawsuit Seeking Alpha - 5/4/2021 5:28:48 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/4/2021 5:16:26 PM
iBio and Fraunhofer USA Conclude Litigation and Enter License Agreement GlobeNewswire Inc. - 5/4/2021 5:00:00 PM
iBio to Participate in the 33rd Annual Roth Conference GlobeNewswire Inc. - 3/9/2021 4:30:00 PM
Despite narrower fiscal Q2 2021 loss, iBio expenses grow; shares fall after hours Seeking Alpha - 2/16/2021 4:54:50 PM
mastaflash   Wednesday, 10/29/14 12:04:34 PM
Re: Kraken3 post# 9212
Post # of 26230 
All, true...I go by filings and company PRs...and all IBIO has ever said is there process COULD be used to make Ebola drugs, and they are prepared to do so if called upon. What's wrong with that?

In the absence of contract or signed agreement, what we have here is:

Speculation: The act of trading in an asset, or conducting a financial transaction, that has a significant risk of losing most or all of the initial outlay, in expectation of a substantial gain.




Some sheep are smarter than others.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences